Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCX354-C in Rheumatoid Arthritis
NCT01027728Phase 2Completed
- Sponsor
- Amgen
- Start
- Dec 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of CCX354 in rheumatoid arthritis (RA), sponsored by Amgen. Started Dec 2009; status: completed.
02
Drugs
CCX354
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01027728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01027728.